The Avextra team (L-R): co-CEO Bernhard Babel, COO Neil Smith, co-CEO David Reckeweg-Lecompte and CSO Marla Luther
March 15, 2023 10:14 AM EDT
Financing
R&D
Manufacturing

Ger­man cannabis med­i­cine man­u­fac­tur­er lands $17M+ in fund­ing

Tyler Patchen

News Reporter

The Ger­man-based cannabis med­i­cine pro­duc­er Avex­tra has reeled in some new funds while al­so look­ing to ex­pand its reach with­in Eu­rope.

Avex­tra an­nounced Wednes­day that …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

A service from the Financial Times